BEAT News and Press, Heartbeam Inc. From 02/26/20

Announces Record Quarterly and Full Year Results MALVERN, Pa., Feb. 26, 2020 (GLOBE NEWSWIRE) -- BioTelemetry, Inc. (NASDAQ:BEAT), the leading remote medical technology company focused on the delivery of health information to improve quality of life and reduce cost of care, today report...

BioTelemetry (NASDAQ: BEAT ) is scheduled to announce Q4 earnings results on Wednesday, February 26th, after market close. The consensus EPS Estimate is $0.27 (-51.8% Y/Y) and the consensus Revenue Estimate is $110.18M (+6.4% Y/Y). Over the last 2 years, BEAT has beaten EPS estimates ...

MALVERN, Pa., Feb. 18, 2020 (GLOBE NEWSWIRE) -- BioTelemetry, Inc. (NASDAQ:BEAT) will release its fourth quarter 2019 earnings on Wednesday, February 26 at 4:00 PM Eastern Time. The BioTelemetry quarterly conference call will be held at 5:00 PM Eastern Time, Wednesday, February 26, 2020....

"I love riding a horse that's running." - David Tepper ( CNBC , 1/17/2020) Seasonal tendencies continue to dominate, overshadowing ongoing elevated readings that are historically coincident with overbought markets. For example, 48.74% of stocks in our ~1,600 stock universe are currently ...

Agilent (NYSE: A ) initiated with Overweight rating and $100 (18% upside) price target at Wells Fargo. More news on: Agilent Technologies, Inc., Avantor, Inc., Axonics Modulation Technologies, Inc., Healthcare stocks news, Stocks on the move, , Read more ...

Investment Thesis I last wrote about BioTelemetry ( BEAT ) at the end of May. At that time the share price had fallen sharply from a February high of $75 to just over $48. It seems likely that BioTel's share price had risen thanks to a collaboration with Apple Health. Apple ( AAPL ) wanted...

BioTelemetry, Inc. (BEAT) Q3 2019 Earnings Conference Call November 05, 2019 5:00 PM ET Company Participants Joseph Capper – President and Chief Executive Officer Heather Getz – Chief Financial Officer Conference Call Participants Brooks O'Neil – Lake Str...

BioTelemetry (NASDAQ: BEAT ): Q3 Non-GAAP EPS of $0.52 beats by $0.04 ; GAAP EPS of $0.23 misses by $0.12 . Revenue of $111.3M (+11.3% Y/Y) in-line. Press Release More news on: BioTelemetry, Inc., Earnings news and commentary, Healthcare stocks news,

Exceeds Expectations Delivers Double Digit Revenue Growth MALVERN, Pa., Nov. 05, 2019 (GLOBE NEWSWIRE) -- BioTelemetry, Inc. (NASDAQ:BEAT), the leading remote medical technology company focused on the delivery of health information to improve quality of life and reduce cost of car...

MALVERN, Pa., Oct. 29, 2019 (GLOBE NEWSWIRE) -- BioTelemetry, Inc. (NASDAQ:BEAT) will release its third quarter 2019 earnings on Tuesday, November 5 at 4:00 PM Eastern Time. The BioTelemetry quarterly conference call will be held at 5:00 PM Eastern Time, Tuesday, November 5, 2019. The br...